C57BL/6JCya-Ptpn3em1/Cya
Common Name:
Ptpn3-KO
Product ID:
S-KO-19216
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Ptpn3-KO
Strain ID
KOCMP-545622-Ptpn3-B6J-VB
Gene Name
Product ID
S-KO-19216
Gene Alias
9530011I20Rik; PTP-H1; PTPCL
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
4
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Ptpn3em1/Cya mice (Catalog S-KO-19216) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000075637
NCBI RefSeq
NM_011207
Target Region
Exon 3~12
Size of Effective Region
~26.1 kb
Detailed Document
Overview of Gene Research
Ptpn3, short for Protein Tyrosine Phosphatase Non-Receptor Type 3, is a member of the membrane-associated non-receptor protein tyrosine phosphatase family. It is involved in multiple cellular processes and has been linked to various signaling pathways, such as the MAPK, PI3K/AKT pathways [1,2,3]. Ptpn3's functions range from affecting cell growth, migration, and invasion to influencing the immune microenvironment, making it biologically significant in both normal physiological processes and disease development. Genetic models, like KO/CKO mouse models, can be valuable for studying its functions in vivo.
In cancer research, Ptpn3 has been found to have diverse roles. In pancreatic cancer, Ptpn3 promotes the proliferation, migration, and invasion of pancreatic ductal adenocarcinoma (PDAC) cells in vitro and tumor growth in a mouse xenograft model, partially through the MAPK pathway, suggesting it could be a therapeutic target [1]. In lung neuroendocrine tumors, Ptpn3 inhibition in cells enhances the anti-tumor effect of activated lymphocytes in mouse xenograft models, and in vitro it is involved in the induction of malignant traits [2]. In clear cell renal cell carcinoma, overexpression of Ptpn3 inhibits cell proliferation, migration, invasion, xenograft tumor growth, and lung metastasis by suppressing the PI3K/AKT signaling pathway, and is an independently favorable prognostic factor [3]. In perihilar cholangiocarcinoma, Ptpn3 suppresses cell proliferation by inhibiting AKT phosphorylation and is a favorable prognostic biomarker [4]. In lung cancer, depletion of Ptpn3 enhances cell migration, invasion, and metastasis by promoting actin filament assembly [5].
In conclusion, Ptpn3 plays crucial roles in regulating cell growth, migration, and invasion, as well as in the tumor immune microenvironment. Studies using mouse models have revealed its significance in various cancer types, highlighting its potential as a therapeutic target in cancer treatment. Additionally, in sheep, SNPs within the Ptpn3 gene are associated with wool production and growth traits, indicating its role in non-disease-related biological processes [6].
References:
1. Onishi, Hideya, Iwamoto, Naoya, Sakanashi, Keita, Ozono, Keigo, Yamasaki, Akio. . PTPN3 Could Βe a Therapeutic Target of Pancreatic Cancer. In Anticancer research, 42, 2869-2874. doi:10.21873/anticanres.15768. https://pubmed.ncbi.nlm.nih.gov/35641270/
2. Koga, Satoko, Onishi, Hideya, Masuda, Shogo, Morisaki, Takashi, Nakamura, Masafumi. 2021. PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor. In Translational oncology, 14, 101152. doi:10.1016/j.tranon.2021.101152. https://pubmed.ncbi.nlm.nih.gov/34134073/
3. Peng, Xing-Si, Yang, Jun-Ping, Qiang, Yuan-Yuan, Huang, Bi-Jun, Qian, Chao-Nan. 2020. PTPN3 Inhibits the Growth and Metastasis of Clear Cell Renal Cell Carcinoma via Inhibition of PI3K/AKT Signaling. In Molecular cancer research : MCR, 18, 903-912. doi:10.1158/1541-7786.MCR-19-1142. https://pubmed.ncbi.nlm.nih.gov/32169891/
4. Sun, Rongqi, Chen, Tianli, Li, Meng, Pan, Chang, Zhang, Zongli. 2019. PTPN3 suppresses the proliferation and correlates with favorable prognosis of perihilar cholangiocarcinoma by inhibiting AKT phosphorylation. In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 121, 109583. doi:10.1016/j.biopha.2019.109583. https://pubmed.ncbi.nlm.nih.gov/31706106/
5. Li, Meng-Yen, Peng, Wen-Hsin, Wu, Chien-Hsun, Wu, Han-Chung, Chen, Guang-Chao. 2019. PTPN3 suppresses lung cancer cell invasiveness by counteracting Src-mediated DAAM1 activation and actin polymerization. In Oncogene, 38, 7002-7016. doi:10.1038/s41388-019-0948-6. https://pubmed.ncbi.nlm.nih.gov/31406243/
6. Wang, Chong, Yuan, Zehu, Hu, Ruixue, Li, Fadi, Yue, Xiangpeng. 2022. Association of SNPs within PTPN3 gene with wool production and growth traits in a dual-purpose sheep population. In Animal biotechnology, 34, 1429-1435. doi:10.1080/10495398.2022.2029465. https://pubmed.ncbi.nlm.nih.gov/35192431/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen